Actinium Pharmaceuticals (ATNM) Shares Issued (2021 - 2024)
Actinium Pharmaceuticals (ATNM) has disclosed Shares Issued for 4 consecutive years, with $75000.0 as the latest value for Q1 2024.
- On a quarterly basis, Shares Issued rose 7400.0% to $75000.0 in Q1 2024 year-over-year; TTM through Dec 2024 was $75000.0, a 71.37% decrease, with the full-year FY2024 number at $75000.0, down 71.37% from a year prior.
- Shares Issued was $75000.0 for Q1 2024 at Actinium Pharmaceuticals, down from $261000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $4.9 million in Q4 2022 to a low of $1000.0 in Q1 2023.
- A 4-year average of $1.0 million and a median of $75000.0 in 2024 define the central range for Shares Issued.
- Biggest YoY gain for Shares Issued was 7400.0% in 2024; the steepest drop was 7400.0% in 2024.
- Actinium Pharmaceuticals' Shares Issued stood at $6000.0 in 2021, then soared by 81466.67% to $4.9 million in 2022, then tumbled by 94.67% to $261000.0 in 2023, then tumbled by 71.26% to $75000.0 in 2024.
- Per Business Quant, the three most recent readings for ATNM's Shares Issued are $75000.0 (Q1 2024), $261000.0 (Q2 2023), and $1000.0 (Q1 2023).